AGREEMENT AND PLAN OF REORGANIZATION by and among SeqLL Inc., as the Purchaser, SEQLL MERGER LLC, as the Purchaser Sub, ATLANTIC ACQUISITION CORP., as Atlantic, ATLANTIC MERGER LLC, as Atlantic Merger Sub, LYNEER INVESTMENTS, LLC, as the Company, IDC...Agreement and Plan of Reorganization • May 31st, 2023 • SeqLL, Inc. • Laboratory analytical instruments • New York
Contract Type FiledMay 31st, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF REORGANIZATION (the “Agreement”) is made as of May 29, 2023 (the “Agreement Date”), by and among (i) Atlantic Acquisition Corp, a Delaware corporation (“Atlantic”), (ii) Atlantic Merger LLC, a Delaware limited liability company and a majority-owned subsidiary of Atlantic (“Atlantic Merger Sub”), (iii) SeqLL Inc., a Delaware corporation (“SeqLL”), (iv) SeqLL Merger LLC, a Delaware limited liability company and a wholly-owned subsidiary of SeqLL (“Purchaser Sub”), (v) Lyneer Investments, LLC, a Delaware limited liability company (the “Company”), (vi) IDC Technologies, Inc., a California corporation (“IDC”), and (vii) Lyneer Management Holdings LLC, a Delaware limited liability company (“Lyneer Management,” and together with IDC, the “Sellers”). Each of Atlantic, Atlantic Merger Sub, SeqLL, Purchaser Sub, the Company and the Sellers are hereinafter referred to as a “Party,” and collectively as the “Parties.”
ASSET PURCHASE AGREEMENT by and between SeqLL Inc. and SeqLL Omics, Inc.Asset Purchase Agreement • May 31st, 2023 • SeqLL, Inc. • Laboratory analytical instruments • Delaware
Contract Type FiledMay 31st, 2023 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of May 29, 2023, by and between SeqLL Inc., a Delaware corporation (“Seller”) on the one hand, and SeqLL Omics, Inc., a Delaware corporation (“Buyer” and, together with Seller, the “Parties” and each individually, a “Party”), on the other hand.